Church & Dwight Firms Up FY Outlook as 3Q Profit, Revenue Rise
Dow Jones2026/10/30 11:21By Adriano Marchese
Church & Dwight firmed up its expectations for net sales and adjusted earnings following a stronger-than-projected third quarter, driven by demand for household staples and personal-care brands.
The consumer packaged goods company on Friday said it has firmed up its sales growth target to 0.5%, within its previous guidance range of between flat and 1% growth. Organic sales growth are expected at the top end of its 4% to 5% range, it noted.
Earnings-per-share growth is expected to grow 20% in the year, while on an adjusted basis, earnings are expected to grow at 7%, compared with a previous range of between 6% and 8%.
For the third quarter, Church & Dwight reported a rise in net income to $212.2 million, or 89 cents a share, compared with $182.2 million, or 75 cents a share, in the same quarter a year ago.
Adjusted earnings came to 92 cents a share, in-line with analyst forecasts, according to FactSet.
Net sales rose 1% to $1.6 billion, its own expectation of a decline of 1%, and analyst forecasts of a modest decline to $1.57 billion.
The company benefited from organic sales growth of 5.1%, topping its 3% target.
Chief Executive Rick Dierker said that the company's brands continue to perform well despite a challenging macroeconomic environment, which helped drive a third consecutive quarter of organic sales growth.
"Our leading brands once again increased share driven by innovation, distribution wins and our targeted marketing investments," Dierker said.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
October 30, 2026 07:21 ET (11:21 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Zcash falls below $1,000 for first time since September
Healthcare Just Hit a Record Lead Over Tech. 3 Things Could Shrink It

BUZZ-Prime Medicine shares fall due to $125 million stock offering